Cargando…
Post‐radiotherapy cribriform‐morular thyroid carcinoma
BACKGROUND: According to the new 2022 World Health Organization classification of endocrine tumors, thyroid malignancy, formerly known as the cribriform‐morular variant of papillary thyroid carcinoma, is now categorized as differentiated thyroid malignancy; it is, at present, called cribriform‐morul...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833981/ https://www.ncbi.nlm.nih.gov/pubmed/36535913 http://dx.doi.org/10.1002/jcla.24819 |
_version_ | 1784868360185446400 |
---|---|
author | Or Koca, Arzu Güler Şimşek, Gülçin |
author_facet | Or Koca, Arzu Güler Şimşek, Gülçin |
author_sort | Or Koca, Arzu |
collection | PubMed |
description | BACKGROUND: According to the new 2022 World Health Organization classification of endocrine tumors, thyroid malignancy, formerly known as the cribriform‐morular variant of papillary thyroid carcinoma, is now categorized as differentiated thyroid malignancy; it is, at present, called cribriform‐morular thyroid carcinoma and classified as a tumor of unknown histogenesis. CASE REPORT: In this case report, we report on a 15‐year‐old patient who underwent external radiotherapy to the neck for Hodgkin's disease and developed cribriform‐morular thyroid carcinoma 5 years after radiotherapy. CONCLUSIONS: We believe that cribriform‐morular thyroid carcinoma with diffuse nuclear beta‐catenin expression has exciting and unresolved uncertainties that may affect disease prognosis and follow‐up for cytopathologists and endocrinologists. |
format | Online Article Text |
id | pubmed-9833981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98339812023-01-13 Post‐radiotherapy cribriform‐morular thyroid carcinoma Or Koca, Arzu Güler Şimşek, Gülçin J Clin Lab Anal Case Report BACKGROUND: According to the new 2022 World Health Organization classification of endocrine tumors, thyroid malignancy, formerly known as the cribriform‐morular variant of papillary thyroid carcinoma, is now categorized as differentiated thyroid malignancy; it is, at present, called cribriform‐morular thyroid carcinoma and classified as a tumor of unknown histogenesis. CASE REPORT: In this case report, we report on a 15‐year‐old patient who underwent external radiotherapy to the neck for Hodgkin's disease and developed cribriform‐morular thyroid carcinoma 5 years after radiotherapy. CONCLUSIONS: We believe that cribriform‐morular thyroid carcinoma with diffuse nuclear beta‐catenin expression has exciting and unresolved uncertainties that may affect disease prognosis and follow‐up for cytopathologists and endocrinologists. John Wiley and Sons Inc. 2022-12-19 /pmc/articles/PMC9833981/ /pubmed/36535913 http://dx.doi.org/10.1002/jcla.24819 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Report Or Koca, Arzu Güler Şimşek, Gülçin Post‐radiotherapy cribriform‐morular thyroid carcinoma |
title | Post‐radiotherapy cribriform‐morular thyroid carcinoma |
title_full | Post‐radiotherapy cribriform‐morular thyroid carcinoma |
title_fullStr | Post‐radiotherapy cribriform‐morular thyroid carcinoma |
title_full_unstemmed | Post‐radiotherapy cribriform‐morular thyroid carcinoma |
title_short | Post‐radiotherapy cribriform‐morular thyroid carcinoma |
title_sort | post‐radiotherapy cribriform‐morular thyroid carcinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833981/ https://www.ncbi.nlm.nih.gov/pubmed/36535913 http://dx.doi.org/10.1002/jcla.24819 |
work_keys_str_mv | AT orkocaarzu postradiotherapycribriformmorularthyroidcarcinoma AT gulersimsekgulcin postradiotherapycribriformmorularthyroidcarcinoma |